Galera Therapeutics, Inc. Profile Avatar - Palmy Investing

Galera Therapeutics, Inc.

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419…

Biotechnology
US, Malvern [HQ]

Resulting Ratios

7 Records · Starting from 2017
Loading...
End of GRTX's Analysis
CIK: 1563577 CUSIP: 36338D108 ISIN: US36338D1081 LEI: - UEI: -
Secondary Listings
GRTX has no secondary listings inside our databases.